About us

Driving Innovation in RNA Interference Research

MDRNA is a science-driven biotechnology company focused on advancing RNA interference (RNAi) research through integrated design, delivery, and preclinical evaluation platforms. We combine expertise in molecular and cellular biology, RNA and peptide chemistry, pharmacology, and bioinformatics to create a robust framework for RNAi discovery and research innovation.

Our mission is to engineer reliable, reproducible, and scalable RNAi tools that support preclinical research and enable partners and collaborators to explore molecular targets efficiently. By integrating siRNA design with advanced delivery technologies and rigorous preclinical workflows, we ensure consistent performance and high-quality experimental data.

Our Approach

Integrated RNAi Platform: Seamlessly connects siRNA design, delivery engineering, and preclinical research.
Data-Driven Design: Computational modeling and empirical validation guide every step of siRNA construct development.
Multidisciplinary Expertise: Scientists and engineers collaborate across biology, chemistry, and analytics to ensure rigorous experimentation.
Collaboration-Ready: Our platform supports internal research programs and external partnerships, offering flexible solutions for a wide range of research applications.

At MD-RNA, we foster an innovative and collaborative environment where technology and science intersect to enable precise, reliable, and efficient RNAi research.